This includes ophthalmic drugs injected or used in conjunction with eye surgery and cardioplegic solutions. Patients should contact their healthcare provider if they experience symptoms of meningitis.
At this time, no cases of infection have been reported in connection with any NECC-produced ophthalmic drug, but the FDA believes the class of products could present similar infection risks.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
